Cargando…
Efficient Treatment of Sporothrix globosa Infection Using the Antibody Elicited by Recombinant Phage Nanofibers
Antifungal therapy is used to treat sporotrichosis. However, there are several limitations in this therapy, such as development of drug resistance and potential health risks including liver injury. The purpose of our study was to evaluate the antifungal efficacy of antibody against the hybrid phage...
Autores principales: | Chen, Feng, Jiang, Rihua, Dong, Shuai, Yan, Bailing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400886/ https://www.ncbi.nlm.nih.gov/pubmed/30873031 http://dx.doi.org/10.3389/fphar.2019.00160 |
Ejemplares similares
-
Recombinant phage displaying ToAP2D peptide with antifungal activity against Sporothrix globosa
por: Yan, Tianyi, et al.
Publicado: (2022) -
Recombinant Phage Elicits Protective Immune Response against Systemic S. globosa Infection in Mouse Model
por: Chen, Feng, et al.
Publicado: (2017) -
Refractory Sporotrichosis Caused by Sporothrix globosa
por: Xia, Xiujiao, et al.
Publicado: (2023) -
Fixed Cutaneous Sporotrichosis Due to Sporothrix globosa
por: Liu, Fang, et al.
Publicado: (2021) -
Influences of the Culturing Media in the Virulence and Cell Wall of Sporothrix schenckii, Sporothrix brasiliensis, and Sporothrix globosa
por: Lozoya-Pérez, Nancy E., et al.
Publicado: (2020)